Menu Search
Equities

Astrana Health Inc

ASTH:NAQ

Astrana Health Inc

Actions
Health CareHealth Care Providers
  • Price (USD)46.96
  • Today's Change-12.12 / -20.51%
  • Shares traded796.47k
  • 1 Year change+46.48%
  • Beta1.1658
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Astrana Health Inc grew revenues 21.19% from 1.14bn to 1.39bn while net income improved 34.42% from 45.17m to 60.72m.
Gross margin16.28%
Net profit margin4.18%
Operating margin6.12%
Return on assets5.84%
Return on equity10.99%
Return on investment6.77%
More ▼

Cash flow in USDView more

In 2023, Astrana Health Inc did not generate a significant amount of cash. However, the company earned 68.23m from its operations for a Cash Flow Margin of 4.92%. In addition the company generated 3.42m cash from financing while 65.52m was spent on investing.
Cash flow per share1.86
Price/Cash flow per share19.76
Book value per share14.28
Tangible book value per share3.22
More ▼

Balance sheet in USDView more

Astrana Health Inc has a Debt to Total Capital ratio of 48.09%, a higher figure than the previous year's 36.43%.
Current ratio1.84
Quick ratio--
Total debt/total equity0.6533
Total debt/total capital0.4809
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 30.58%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)35.25
EPS (TTM) vs
TTM 1 year ago		46.86
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.